U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. SHINGRIX
  1. Vaccines

SHINGRIX

STN: 125614
Proper Name: Zoster Vaccine Recombinant, Adjuvanted
Tradename: SHINGRIX
Manufacturer: GlaxoSmithKline Biologicals
Indication:

SHINGRIX is a vaccine indicated for prevention of herpes zoster (HZ) (shingles):

  • in adults aged 50 years and older.
  • in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy.

Limitations of Use:

  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox).

Product Information

Supporting Documents

Back to Top